Karl Naegler - Profile and Investment Details

Investor Profile

Karl Naegler is a Venture Capital based in Munich, Bavaria, Germany with a diverse investment portfolio that includes companies such as UiPath, Heliatek, import.io, invendo medical, Hintsa, ImevaX, Confo Therapeutics, Ztory, Rigontec, Atopix Therapeutics, immatics biotechnologies, GLO, NEUWAY Pharma, ImCheck Therapeutics, Onfido, Themis Bioscience, Soundtrack Your Brand, Zopa, AYOXXA, YPlan, AMBOSS, 4SC, Edge Intelligence Software, Blackbuck, Polares Medical, Wool and the Gang, Middle Peak Medical, UroMems, 4TEEN4 Pharmaceuticals, EGenesis, Carisma Therapeutics, Minervax, Definiens, Nosto, GTX medical, STipe Therapeutics, Workframe, Dalia Research, Quanta, SidekickHealth, Festicket, Artfinder, Mapillary, Orcan Energy, Jellynote, Dacuda, SNIPR Biome, Koa Health, SumAll, Cavendish Kinetics, FREE NOW, EndoStim, IconOVir Bio, SuperSonic Imagine, opvizor, Tricares, Adrenomed, IOmx Therapeutics, EyeEm, Tonsser, SIRS Therapeutics, Genticel. Over time, Karl Naegler has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Karl Naegler is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Wellness, Women Founded, Life Science, Biotech, Medical Device, Healthcare, Biotechnology, Genomics, Natural Language Processing, Medical, Therapeutics, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Karl Naegler, as their portfolio suggests a familiarity and interest in this area.

Understanding Karl Naegler’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.